Control and patient-derived primary fibroblasts were propagated in RPMI 1640 medium (TermoFisher Scientific) supplemented with 15% heat-inactivated low-endotoxin fetal bovine serum (TermoFisher Scientific), 100 U/ml penicillin and 100 mg/ml streptomycin.
Control and patient-derived lymphoblastoid cell lines (LCLs) were propagated in RPMI 1640 medium (TermoFisher Scientific) supplemented with 20% heat-inactivated low-endotoxin fetal bovine serum (TermoFisher Scientific), 100 U/ml penicillin and 100 mg/ml streptomycin.
Cells were maintained at 37°C under a 5% CO2 atmosphere.
To stimulate the endogenous heme synthesis cells were treated with 5mM ALA (A3785; Sigma-Aldrich).
To facilitate heme efflux through FLVCR1a, LCLs were stimulated with 5μM or 15μM Hemopexin (CSL; Behring) under starved conditions.